Parallel Advisors’s Cocrystal Pharma COCP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $22.7K | Hold |
15,228
| – | – | ﹤0.01% | 2117 |
|
2025
Q1 | $22.4K | Hold |
15,228
| – | – | ﹤0.01% | 2067 |
|
2024
Q4 | $30.8K | Hold |
15,228
| – | – | ﹤0.01% | 1908 |
|
2024
Q3 | $26.8K | Buy |
+15,228
| New | +$26.8K | ﹤0.01% | 1912 |
|
2023
Q3 | – | Sell |
-15,228
| Closed | -$36.4K | – | 3369 |
|
2023
Q2 | $36.4K | Hold |
15,228
| – | – | ﹤0.01% | 1560 |
|
2023
Q1 | $30.3K | Hold |
15,228
| – | – | ﹤0.01% | 1626 |
|
2022
Q4 | $29.7K | Buy |
15,228
+2
| +0% | +$4 | ﹤0.01% | 1525 |
|
2022
Q3 | $53K | Hold |
15,226
| – | – | ﹤0.01% | 1229 |
|
2022
Q2 | $75K | Hold |
15,226
| – | – | ﹤0.01% | 1068 |
|
2022
Q1 | $102K | Hold |
15,226
| – | – | ﹤0.01% | 977 |
|
2021
Q4 | $119K | Hold |
15,226
| – | – | ﹤0.01% | 934 |
|
2021
Q3 | $192K | Sell |
15,226
-166
| -1% | -$2.09K | 0.01% | 727 |
|
2021
Q2 | $231K | Sell |
15,392
-750
| -5% | -$11.3K | 0.01% | 625 |
|
2021
Q1 | $269K | Sell |
16,142
-709
| -4% | -$11.8K | 0.01% | 534 |
|
2020
Q4 | $275K | Buy |
16,851
+6,137
| +57% | +$100K | 0.01% | 485 |
|
2020
Q3 | $120K | Hold |
10,714
| – | – | 0.01% | 694 |
|
2020
Q2 | $195K | Hold |
10,714
| – | – | 0.01% | 544 |
|
2020
Q1 | $91K | Buy |
10,714
+6,619
| +162% | +$56.2K | 0.01% | 705 |
|
2019
Q4 | $24K | Buy |
4,095
+53
| +1% | +$311 | ﹤0.01% | 1306 |
|
2019
Q3 | $99K | Buy |
+4,042
| New | +$99K | 0.01% | 711 |
|